The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Whats often not discussed regarding large salaries funded by the taxpayer is that the recipients often take early retirement on something approaching two thirds final salary and recruitment starts over again. Its a fallacy to suggest that positions wouldnt be filled by talented people if lesser salaries were offered. There are plenty of talented folk who don't have the benefit of private education, but then where would the likes of Giles and Sophia and their ilk work and how would they afford their Range Rovers. You know what as a life long Conservative I may actually vote Labour next time around.
Heard on Radio 4 News this morning that the NHS is struggling with the cost of Chemotherapy for advanced Cancer patients. Wouldnt it be helpful if Chemo drugs could target tumours very precisely so that none of the chemo drug escapes the tumour and treatment could be reduced. Enter AVA 6000 ...
"Lost all Confidence " - I make it a point not to recommend buying or selling anymore since everyones situation is different, but what I would say is that when and if this tanker turns on good news in respect of LFTs and AVA6000 in the next weeks it will likely shoot through +50% without pausing for breath then on to 600p or more in short order. Against that on bad news it could go down say 40% and stay between that and 100p ish for some months to perhaps a year before some of the less talked about prospects start to deliver. All in my own opinion of course and no guarantees but read MMs 'Aim Chaos' if you want some depth. Not reading bulletin boards might be a good idea until news lands. I hope that helps.
Just to say the LFT business that has been established over the last 12 months is bigger than Covid and to a degree underwrites the share price. Point Biopharma's engagement with Affimers is growing and underwrites the share price to a degree, BAMS has not died, ELISA tests are being sold. Affimers themselves are worth a fortune and continue to be marketed in a world where Antibodies developed in animals are to be phased out. In my own opinion there are plenty of opportunities to regain the 280p if all else goes tits up and 2500p disappears over the horizon.
For cruise liners in particular stating that fellow passengers will be tested and confirmed Covid free with an easy painless and high accuracy LFT s a huge selling point. Why Airlines would hesitate to offer the same defies logic in my opinion.
Bella "No but ..." , one has to wonder why the whole focus of the enterprise wouldnt be on Affimers from the outset given that the EU is calling for Antibody use to be phased out in coming years and given the cost and stability benefits Affimers offer.
What many investors seem not to recognise (still) is that massive sales of the AffiDX is not essential to Avactas success. Avacta has built a Diagnostics business over the last twelve months, which is itself worth many millions and which Global Pharma is well aware of and watching closely. If AffiDx earns a few tens of millions thats more than enough to avoid future cash calls, so job done. AVA 6000 and everything else is what will, for the most part, yield a share price north of 2500p. Patience is all and if AffiDX does earn large then so much the better.
May be 113 potential suppliers but one test is more accurate than all the others and very easy to perform. So sales will likely favour Avacta. Good times are a coming.
A fine example of changing rules when it suits the Government. Yes, why is everybody not paying 700p for an LFT and having a PCR test if and only if they test positive. Answer because its too bloody sensible. You just couldnt make it up.
Strange to be retweeting at this time of the day:
https://www.ddw-online.com/building-a-pipeline-of-clinically-differentiated-cancer-therapies-13092-202109/
To be frank it would be crass stupidity for the Government not to purchase the best LFT in the world particularly when its made in Britain with British technology and IP. This fact must surely at some stage be all over the media. I think its up to AS to shout about it.
Yes "we were saying the same thing last year"and one day we will be right. I dont mind waiting a while. When alls said and done, Frome (town in England) wasnt built in a day. I was looking for "Raging Buy" in the drop down but couldnt find it!
An object lesson in the difference between value and price I guess. Felt sure that today was THE day. Anyway who wouldnt buy a share priced at 140p that just might be worth 500p by Christmas? Answers on a postcard please ...
Yes how right you are. Having seen the graph showing how the protection afforded by vaccination drops off to 50% or less after 4 months and that the pfizer vaccination drops below AZ on quite a steep downward curve after that was I surprised to see the BBC graph stop at the 3 month point? Answer not one bl**dy bit. The public are being played and the BBC are the orchestra.
My feeling is that Al is hoping that the golden eggs will be laid before the Sept presentation. Hens ate looking broody but we are not there yet. Quite possible an RNS or two will land before then of course. Quite reassured by the complete absence of LFT chat. We all know where we are and that the share price is currently disconnected from the reality of Avacta worth. But hey ho, times they are a changing.